Yukako Sagara

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Nanofiber-based platform for quantitative analysis of human oligodendrocyte ensheathment with pharmacological perturbations.

Nanofiber-based platform for quantitative analysis of human oligodendrocyte ensheathment with pharmacological perturbations.

Journal: Stem cell reports

Published: September 18, 2025

Induced pluripotent stem cell-based assays recapture multiple properties of human astrocytes.

Induced pluripotent stem cell-based assays recapture multiple properties of human astrocytes.

Journal: Journal of cellular and molecular medicine

Published: September 22, 2023

Phototoxicity avoidance is a potential therapeutic approach for retinal dystrophy caused by EYS dysfunction.

Phototoxicity avoidance is a potential therapeutic approach for retinal dystrophy caused by EYS dysfunction.

Journal: JCI insight

Published: July 24, 2023

Establishment of induced pluripotent stem cells from schizophrenia discordant fraternal twins.

Establishment of induced pluripotent stem cells from schizophrenia discordant fraternal twins.

Journal: Stem cell research

Published: August 03, 2021

One-step induction of photoreceptor-like cells from human iPSCs by delivering transcription factors.

One-step induction of photoreceptor-like cells from human iPSCs by delivering transcription factors.

Journal: iScience

Published: July 13, 2021

Human induced pluripotent stem cells generated from a patient with idiopathic basal ganglia calcification.

Human induced pluripotent stem cells generated from a patient with idiopathic basal ganglia calcification.

Journal: Stem cell research

Published: November 19, 2020

Generation of a human induced pluripotent stem cell line, BRCi009-A, derived from a patient with glycogen storage disease type 1a.

Generation of a human induced pluripotent stem cell line, BRCi009-A, derived from a patient with glycogen storage disease type 1a.

Journal: Stem cell research

Published: November 10, 2020

Generation of a human induced pluripotent stem cell line, BRCi004-A, derived from a patient with age-related macular degeneration.

Generation of a human induced pluripotent stem cell line, BRCi004-A, derived from a patient with age-related macular degeneration.

Journal: Stem cell research

Published: February 22, 2020

Generation of a human induced pluripotent stem cell line, BRCi005-A, derived from a Best disease patient with BEST1 mutations.

Generation of a human induced pluripotent stem cell line, BRCi005-A, derived from a Best disease patient with BEST1 mutations.

Journal: Stem cell research

Published: February 22, 2020

Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type I.

Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type I.

Journal: Stem cell research

Published: October 10, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026